Author

Stella Mayo McCaughey

Observed name: Stella McCaughey

Institution: Alector (United States)

Observed institutions: University of Washington, Alector (United States)

OpenAlex ID: A5017955878

Progranulin as a therapeutic target in neurodegenerative diseases

2022 · Herve Rhinn, Nadine Tatton, et al. · Trends in Pharmacological Sciences · 206

Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors

2011 · Esther D. Quakkelaar, Anke Redeker, et al. · PLoS ONE · 50

ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans

2009 · Lichen Jing, Stella Mayo McCaughey, et al. · Journal of Immunological Methods · 28

The role of neurofilament light in genetic frontotemporal lobar degeneration

2022 · Henrik Zetterberg, Charlotte Teunissen, et al. · Brain Communications · 19

Development of a Speech-based Composite Score for Remotely Quantifying Language Changes in Frontotemporal Dementia

2023 · Jessica Robin, Mengdan Xu, et al. · Cognitive and Behavioral Neurology · 8

Analyzing Medical Claims Data to Identify Health Care Provider Specialties Diagnosing Frontotemporal Dementia

2022 · Devon Chenette, Stella McCaughey, et al. · Alzheimer s & Dementia · 1

AL001 Blocks the Sortilin/PGRN Interaction and is a Potential Therapy for FTD-GRN (4422)

2021 · Robert Paul, Hua Long, et al. · Neurology · 1

Genetic testing rates of individuals diagnosed with FTD and close biological relatives assessed in the FTD Insights Survey

2025 · Devon M Chenette, Stella McCaughey, et al. · Alzheimer s & Dementia

25. Exploring Quality of Life Impact Reported by Caregivers in the Ftd Insights Survey

2025 · Devon Chenette, Stella McCaughey, et al. · American Journal of Geriatric Psychiatry

Exploring Quality of Life Impact Reported by Caregivers in the FTD Insights Survey (P11-3.010)

2025 · Devon Chenette, Stella McCaughey, et al. · Neurology

Development of the Monoclonal Antibody AL101 to block the Sortilin/Progranulin Interaction as a Potential Therapy for Neurodegenerative Diseases (P6-3.003)

2022 · Ananya Mitra, Robert Paul, et al. · Neurology

Development of a novel digital speech composite measure for Frontotemporal Dementia (P7-3.002)

2022 · Jessica Robin, Mengdan Xu, et al. · Neurology

Vaccinia-specific CD4 T-cell responses in humans are predominantly restricted by HLA DR (132.22)

2009 · Lichen Jing, Stella Mayo McCaughey, et al. · The Journal of Immunology

Works count: 13

Citation count: 313

H-index: 5

I10-index: 4